{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:20:25Z","timestamp":1787941225226,"version":"build-2784847793"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Youth Foundation of Shandong Natural Science Foundation of China","award":["ZR2026QC0926"],"award-info":[{"award-number":["ZR2026QC0926"]}]},{"name":"Youth Foundation of Shandong Natural Science Foundation of China","award":["ZR2026QC0857"],"award-info":[{"award-number":["ZR2026QC0857"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"DOI":"10.1007\/s11154-026-10084-z","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:41:19Z","timestamp":1787895679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The central role of the \u03b2-cell in diabetes: from monogenic forms to type 1, type 2, and gestational diabetes"],"prefix":"10.1007","author":[{"given":"Zhaoying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"9","key":"10084_CR1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","volume":"19","author":"MJ Redondo","year":"2023","unstructured":"Redondo MJ, Morgan NG. Heterogeneity and endotypes in type 1 diabetes mellitus. Nat Rev Endocrinol. 2023;19(9):542\u201354.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10084_CR2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00125-020-05159-8","volume":"63","author":"EDR Arrojo","year":"2020","unstructured":"Arrojo EDR, Roy B, MacDonald PE. Molecular and functional profiling of human islets: from heterogeneity to human phenotypes. Diabetologia. 2020;63(10):2095\u2013101.","journal-title":"Diabetologia"},{"issue":"4","key":"10084_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/dbi17-0040","volume":"67","author":"RKP Benninger","year":"2018","unstructured":"Benninger RKP, Hodson DJ. New Understanding of beta-Cell Heterogeneity and In Situ Islet Function. Diabetes. 2018;67(4):537\u201347.","journal-title":"Diabetes"},{"issue":"5","key":"10084_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.2337\/dci23-0038","volume":"47","author":"SI Stone","year":"2024","unstructured":"Stone SI, Balasubramanyam A, Posey JE. Atypical Diabetes: What Have We Learned and What Does the Future Hold? Diabetes Care. 2024;47(5):770\u201381.","journal-title":"Diabetes Care"},{"issue":"7","key":"10084_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","volume":"16","author":"DL Eizirik","year":"2020","unstructured":"Eizirik DL, Pasquali L, Cnop M. Pancreatic beta-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020;16(7):349\u201362.","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 1","key":"10084_CR6","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"American Diabetes Association Professional Practice C","year":"2022","unstructured":"American Diabetes Association Professional Practice C. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17\u201338.","journal-title":"Diabetes Care"},{"issue":"11","key":"10084_CR7","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2337\/dc16-0645","volume":"39","author":"M Shepherd","year":"2016","unstructured":"Shepherd M, Shields B, Hammersley S, Hudson M, McDonald TJ, Colclough K, et al. Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. Diabetes Care. 2016;39(11):1879\u201388.","journal-title":"Diabetes Care"},{"issue":"1","key":"10084_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12916-017-0977-3","volume":"15","author":"V Bansal","year":"2017","unstructured":"Bansal V, Gassenhuber J, Phillips T, Oliveira G, Harbaugh R, Villarasa N, et al. Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals. BMC Med. 2017;15(1):213.","journal-title":"BMC Med"},{"issue":"10","key":"10084_CR9","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1210\/jc.2013-1279","volume":"98","author":"C Pihoker","year":"2013","unstructured":"Pihoker C, Gilliam LK, Ellard S, Dabelea D, Davis C, Dolan LM, et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab. 2013;98(10):4055\u201362.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10084_CR10","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.2337\/dci20-0065","volume":"43","author":"MC Riddle","year":"2020","unstructured":"Riddle MC, Philipson LH, Rich SS, Carlsson A, Franks PW, Greeley SAW, et al. Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors\u2019 Expert Forum. Diabetes Care. 2020;43(12):3117\u201328.","journal-title":"Diabetes Care"},{"issue":"9","key":"10084_CR11","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00125-020-05181-w","volume":"63","author":"WK Chung","year":"2020","unstructured":"Chung WK, Erion K, Florez JC, Hattersley AT, Hivert MF, Lee CG, et al. Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2020;63(9):1671\u201393.","journal-title":"Diabetologia"},{"issue":"6371","key":"10084_CR12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/356721a0","volume":"356","author":"N Vionnet","year":"1992","unstructured":"Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature. 1992;356(6371):721\u20132.","journal-title":"Nature"},{"issue":"6","key":"10084_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2337\/diab.39.6.647","volume":"39","author":"FM Matschinsky","year":"1990","unstructured":"Matschinsky FM. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes. 1990;39(6):647\u201352.","journal-title":"Diabetes"},{"issue":"3","key":"10084_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jama.2013.283980","volume":"311","author":"AM Steele","year":"2014","unstructured":"Steele AM, Shields BM, Wensley KJ, Colclough K, Ellard S, Hattersley AT. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA. 2014;311(3):279\u201386.","journal-title":"JAMA"},{"issue":"1","key":"10084_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00125-013-3075-x","volume":"57","author":"A Stride","year":"2014","unstructured":"Stride A, Shields B, Gill-Carey O, Chakera AJ, Colclough K, Ellard S, et al. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetologia. 2014;57(1):54\u20136.","journal-title":"Diabetologia"},{"issue":"10","key":"10084_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, et al. The Human Gene Mutation Database (HGMD((R))): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020;139(10):1197\u2013207.","journal-title":"Hum Genet"},{"issue":"12","key":"10084_CR17","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s00125-010-1799-4","volume":"53","author":"BM Shields","year":"2010","unstructured":"Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia. 2010;53(12):2504\u20138.","journal-title":"Diabetologia"},{"issue":"1","key":"10084_CR18","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1038\/s41467-024-48647-w","volume":"15","author":"NHJ Ng","year":"2024","unstructured":"Ng NHJ, Ghosh S, Bok CM, Ching C, Low BSJ, Chen JT, et al. HNF4A and HNF1A exhibit tissue specific target gene regulation in pancreatic beta cells and hepatocytes. Nat Commun. 2024;15(1):4288.","journal-title":"Nat Commun"},{"key":"10084_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142244","author":"H Zhang","year":"2021","unstructured":"Zhang H, Colclough K, Gloyn AL, Pollin TI. Monogenic diabetes: a gateway to precision medicine in diabetes. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI142244.","journal-title":"J Clin Invest"},{"issue":"7","key":"10084_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1046\/j.1464-5491.2000.00305.x","volume":"17","author":"ER Pearson","year":"2000","unstructured":"Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med. 2000;17(7):543\u20135.","journal-title":"Diabet Med"},{"issue":"1","key":"10084_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.stem.2022.12.001","volume":"30","author":"FM Hermann","year":"2023","unstructured":"Hermann FM, Kjaergaard MF, Tian C, Tiemann U, Jackson A, Olsen LR, et al. An insulin hypersecretion phenotype precedes pancreatic beta cell failure in MODY3 patient-specific cells. Cell Stem Cell. 2023;30(1):38\u201351. e8.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10084_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clp.2017.10.006","volume":"45","author":"MB Lemelman","year":"2018","unstructured":"Lemelman MB, Letourneau L, Greeley SAW. Neonatal Diabetes Mellitus: An Update on Diagnosis and Management. Clin Perinatol. 2018;45(1):41\u201359.","journal-title":"Clin Perinatol"},{"issue":"9997","key":"10084_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)60098-8","volume":"386","author":"E De Franco","year":"2015","unstructured":"De Franco E, Flanagan SE, Houghton JA, Lango Allen H, Mackay DJ, Temple IK, et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 2015;386(9997):957\u201363.","journal-title":"Lancet"},{"issue":"5","key":"10084_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1056\/NEJMoa061759","volume":"355","author":"ER Pearson","year":"2006","unstructured":"Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006;355(5):467\u201377.","journal-title":"N Engl J Med"},{"issue":"4","key":"10084_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1464-5491.2008.02359.x","volume":"25","author":"R Murphy","year":"2008","unstructured":"Murphy R, Turnbull DM, Walker M, Hattersley AT. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A\u2009>\u2009G mitochondrial point mutation. Diabet Med. 2008;25(4):383\u201399.","journal-title":"Diabet Med"},{"issue":"1","key":"10084_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41572-023-00421-w","volume":"9","author":"A Bonnefond","year":"2023","unstructured":"Bonnefond A, Unnikrishnan R, Doria A, Vaxillaire M, Kulkarni RN, Mohan V, et al. Monogenic diabetes. Nat Rev Dis Primers. 2023;9(1):12.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10084_CR27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00125-017-4226-2","volume":"60","author":"AT Hattersley","year":"2017","unstructured":"Hattersley AT, Patel KA. Precision diabetes: learning from monogenic diabetes. Diabetologia. 2017;60(5):769\u201377.","journal-title":"Diabetologia"},{"key":"10084_CR28","doi-asserted-by":"crossref","unstructured":"Sharp LN, Mirshahi UL, Colclough K, Hall TS, Haley JS, Cannon SJ et al. MODY Is Prevalent in Later-Onset Diabetes and Has Potential for Targeted Therapy but Is Challenging to Identify. Diabetes. 2026;75(2):361-368.","DOI":"10.2337\/db25-0545"},{"issue":"11","key":"10084_CR29","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ajhg.2022.09.014","volume":"109","author":"UL Mirshahi","year":"2022","unstructured":"Mirshahi UL, Colclough K, Wright CF, Wood AR, Beaumont RN, Tyrrell J, et al. Reduced penetrance of MODY-associated HNF1A\/HNF4A variants but not GCK variants in clinically unselected cohorts. Am J Hum Genet. 2022;109(11):2018\u201328.","journal-title":"Am J Hum Genet"},{"key":"10084_CR30","doi-asserted-by":"publisher","first-page":"920390","DOI":"10.3389\/fgene.2022.920390","volume":"13","author":"R Kingdom","year":"2022","unstructured":"Kingdom R, Wright CF. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts. Front Genet. 2022;13:920390.","journal-title":"Front Genet"},{"issue":"9","key":"10084_CR31","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/s42255-025-01372-0","volume":"7","author":"J Murray Leech","year":"2025","unstructured":"Murray Leech J, Beaumont RN, Arni AM, Chundru VK, Sharp LN, Colclough K, et al. Common genetic variants modify disease risk and clinical presentation in monogenic diabetes. Nat Metab. 2025;7(9):1819\u201329.","journal-title":"Nat Metab"},{"key":"10084_CR32","doi-asserted-by":"publisher","first-page":"e075681","DOI":"10.1136\/bmj-2023-075681","volume":"384","author":"S Subramanian","year":"2024","unstructured":"Subramanian S, Khan F, Hirsch IB. New advances in type 1 diabetes. BMJ. 2024;384:e075681.","journal-title":"BMJ"},{"issue":"5","key":"10084_CR33","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00125-021-05398-3","volume":"64","author":"BJ von Scholten","year":"2021","unstructured":"von Scholten BJ, Kreiner FF, Gough SCL, von Herrath M. Current and future therapies for type 1 diabetes. Diabetologia. 2021;64(5):1037\u201348.","journal-title":"Diabetologia"},{"issue":"12","key":"10084_CR34","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1210\/clinem\/dgad328","volume":"108","author":"KM Simmons","year":"2023","unstructured":"Simmons KM, Sims EK. Screening and Prevention of Type 1 Diabetes: Where Are We? J Clin Endocrinol Metab. 2023;108(12):3067\u201379.","journal-title":"J Clin Endocrinol Metab"},{"key":"10084_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aao4013","author":"S Culina","year":"2018","unstructured":"Culina S, Lalanne AI, Afonso G, Cerosaletti K, Pinto S, Sebastiani G, et al. Islet-reactive CD8(+) T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci Immunol. 2018;3(20):eaao4013 . https:\/\/doi.org\/10.1126\/sciimmunol.aao4013","journal-title":"Sci Immunol"},{"issue":"1","key":"10084_CR36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1172\/JCI126595","volume":"130","author":"AE Wiedeman","year":"2020","unstructured":"Wiedeman AE, Muir VS, Rosasco MG, DeBerg HA, Presnell S, Haas B, et al. Autoreactive CD8\u2009+\u2009T cell exhaustion distinguishes subjects with slow type 1 diabetes progression. J Clin Invest. 2020;130(1):480\u201390.","journal-title":"J Clin Invest"},{"issue":"3","key":"10084_CR37","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2337\/db14-0332","volume":"64","author":"A Skowera","year":"2015","unstructured":"Skowera A, Ladell K, McLaren JE, Dolton G, Matthews KK, Gostick E, et al. beta-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure. Diabetes. 2015;64(3):916\u201325.","journal-title":"Diabetes"},{"issue":"6","key":"10084_CR38","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cmet.2018.07.007","volume":"28","author":"S Gonzalez-Duque","year":"2018","unstructured":"Gonzalez-Duque S, Azoury ME, Colli ML, Afonso G, Turatsinze JV, Nigi L, et al. Conventional and Neo-antigenic Peptides Presented by beta Cells Are Targeted by Circulating Naive CD8\u2009+\u2009T Cells in Type 1 Diabetic and Healthy Donors. Cell Metab. 2018;28(6):946\u201360. e6.","journal-title":"Cell Metab"},{"key":"10084_CR39","doi-asserted-by":"crossref","unstructured":"Hansen MS, Pokharel P, Piganelli J, Sussel L. The Chicken or the Egg Dilemma: Understanding the Interplay between the Immune System and the beta Cell in Type 1 Diabetes. Cold Spring Harb Perspect Med. 2025;15(4):a041591.","DOI":"10.1101\/cshperspect.a041591"},{"issue":"2","key":"10084_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00125-019-05032-3","volume":"63","author":"LA Claessens","year":"2020","unstructured":"Claessens LA, Wesselius J, van Lummel M, Laban S, Mulder F, Mul D, et al. Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes. Diabetologia. 2020;63(2):351\u201361.","journal-title":"Diabetologia"},{"issue":"3","key":"10084_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cei.12687","volume":"182","author":"VB Gibson","year":"2015","unstructured":"Gibson VB, Nikolic T, Pearce VQ, Demengeot J, Roep BO, Peakman M. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model. Clin Exp Immunol. 2015;182(3):251\u201360.","journal-title":"Clin Exp Immunol"},{"issue":"41","key":"10084_CR42","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1073\/pnas.1710415114","volume":"114","author":"S Tan","year":"2017","unstructured":"Tan S, Li Y, Xia J, Jin CH, Hu Z, Duinkerken G, et al. Type 1 diabetes induction in humanized mice. Proc Natl Acad Sci U S A. 2017;114(41):10954\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10084_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S2213-8587(18)30112-8","volume":"7","author":"MA Atkinson","year":"2019","unstructured":"Atkinson MA, Roep BO, Posgai A, Wheeler DCS, Peakman M. The challenge of modulating beta-cell autoimmunity in type 1 diabetes. Lancet Diabetes Endocrinol. 2019;7(1):52\u201364.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10084_CR44","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2249.2009.04087.x","volume":"159","author":"BO Roep","year":"2010","unstructured":"Roep BO, Kleijwegt FS, van Halteren AG, Bonato V, Boggi U, Vendrame F, et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol. 2010;159(3):338\u201343.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10084_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20111187","volume":"209","author":"KT Coppieters","year":"2012","unstructured":"Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med. 2012;209(1):51\u201360.","journal-title":"J Exp Med"},{"issue":"Suppl","key":"10084_CR46","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1016\/j.molmet.2019.06.010","volume":"27S","author":"EK Sims","year":"2019","unstructured":"Sims EK, DiMeglio LA. Cause or effect? A review of clinical data demonstrating beta cell dysfunction prior to the clinical onset of type 1 diabetes. Mol Metab. 2019;27S(Suppl):S129\u201338.","journal-title":"Mol Metab"},{"key":"10084_CR47","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162123","author":"K Warncke","year":"2022","unstructured":"Warncke K, Weiss A, Achenbach P, von dem Berge T, Berner R, Casteels K, et al. Elevations in blood glucose before and after the appearance of islet autoantibodies in children. J Clin Invest. 2022;132(20):e162123. https:\/\/doi.org\/10.1172\/JCI162123","journal-title":"J Clin Invest"},{"issue":"8","key":"10084_CR48","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","volume":"24","author":"F Ovalle","year":"2018","unstructured":"Ovalle F, Grimes T, Xu G, Patel AJ, Grayson TB, Thielen LA, et al. Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat Med. 2018;24(8):1108\u201312.","journal-title":"Nat Med"},{"issue":"3","key":"10084_CR49","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s001250051626","volume":"44","author":"MJ Redondo","year":"2001","unstructured":"Redondo MJ, Yu L, Hawa M, Mackenzie T, Pyke DA, Eisenbarth GS, et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001;44(3):354\u201362.","journal-title":"Diabetologia"},{"key":"10084_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fendo.2020.00119","volume":"11","author":"H Pang","year":"2020","unstructured":"Pang H, Luo S, Huang G, Xia Y, Xie Z, Zhou Z. Advances in Knowledge of Candidate Genes Acting at the Beta-Cell Level in the Pathogenesis of T1DM. Front Endocrinol (Lausanne). 2020;11:119.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10084_CR51","doi-asserted-by":"publisher","first-page":"e1002552","DOI":"10.1371\/journal.pgen.1002552","volume":"8","author":"DL Eizirik","year":"2012","unstructured":"Eizirik DL, Sammeth M, Bouckenooghe T, Bottu G, Sisino G, Igoillo-Esteve M, et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 2012;8(3):e1002552.","journal-title":"PLoS Genet"},{"issue":"4","key":"10084_CR52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2009.21","volume":"5","author":"DL Eizirik","year":"2009","unstructured":"Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 2009;5(4):219\u201326.","journal-title":"Nat Rev Endocrinol"},{"key":"10084_CR53","doi-asserted-by":"publisher","first-page":"101365","DOI":"10.1016\/j.molmet.2021.101365","volume":"54","author":"GS Sahin","year":"2021","unstructured":"Sahin GS, Lee H, Engin F. An accomplice more than a mere victim: The impact of beta-cell ER stress on type 1 diabetes pathogenesis. Mol Metab. 2021;54:101365.","journal-title":"Mol Metab"},{"key":"10084_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fcell.2015.00067","volume":"3","author":"ML Marre","year":"2015","unstructured":"Marre ML, James EA, Piganelli JD. beta cell ER stress and the implications for immunogenicity in type 1 diabetes. Front Cell Dev Biol. 2015;3:67.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10084_CR55","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.2337\/db17-1166","volume":"67","author":"ML Marre","year":"2018","unstructured":"Marre ML, McGinty JW, Chow IT, DeNicola ME, Beck NW, Kent SC, et al. Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4(+) T Cells in Patients With Type 1 Diabetes. Diabetes. 2018;67(7):1356\u201368.","journal-title":"Diabetes"},{"issue":"6","key":"10084_CR56","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2337\/dbi17-0030","volume":"67","author":"EA James","year":"2018","unstructured":"James EA, Pietropaolo M, Mamula MJ. Immune Recognition of beta-Cells: Neoepitopes as Key Players in the Loss of Tolerance. Diabetes. 2018;67(6):1035\u201342.","journal-title":"Diabetes"},{"issue":"12","key":"10084_CR57","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/nm.4203","volume":"22","author":"JA Babon","year":"2016","unstructured":"Babon JA, DeNicola ME, Blodgett DM, Crevecoeur I, Buttrick TS, Maehr R, et al. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nat Med. 2016;22(12):1482\u20137.","journal-title":"Nat Med"},{"issue":"12","key":"10084_CR58","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.2337\/db20-0013","volume":"69","author":"ME Azoury","year":"2020","unstructured":"Azoury ME, Tarayrah M, Afonso G, Pais A, Colli ML, Maillard C, et al. Peptides Derived From Insulin Granule Proteins Are Targeted by CD8(+) T Cells Across MHC Class I Restrictions in Humans and NOD Mice. Diabetes. 2020;69(12):2678\u201390.","journal-title":"Diabetes"},{"issue":"12","key":"10084_CR59","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","volume":"25","author":"K Vehik","year":"2019","unstructured":"Vehik K, Lynch KF, Wong MC, Tian X, Ross MC, Gibbs RA, et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat Med. 2019;25(12):1865\u201372.","journal-title":"Nat Med"},{"issue":"12","key":"10084_CR60","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s00125-022-05779-2","volume":"65","author":"L Krogvold","year":"2022","unstructured":"Krogvold L, Genoni A, Puggioni A, Campani D, Richardson SJ, Flaxman CS, et al. Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study. Diabetologia. 2022;65(12):2108\u201320.","journal-title":"Diabetologia"},{"issue":"5","key":"10084_CR61","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2337\/dc22-0385","volume":"46","author":"PM McKeigue","year":"2023","unstructured":"McKeigue PM, McGurnaghan S, Blackbourn L, Bath LE, McAllister DA, Caparrotta TM, et al. Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland. Diabetes Care. 2023;46(5):921\u20138.","journal-title":"Diabetes Care"},{"issue":"7","key":"10084_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41574-023-00826-3","volume":"19","author":"DL Eizirik","year":"2023","unstructured":"Eizirik DL, Szymczak F, Mallone R. Why does the immune system destroy pancreatic beta-cells but not alpha-cells in type 1 diabetes? Nat Rev Endocrinol. 2023;19(7):425\u201334.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10084_CR63","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S2213-8587(24)00090-1","volume":"12","author":"RD Leslie","year":"2024","unstructured":"Leslie RD. Type 1 diabetes: heterogeneity in heritability. Lancet Diabetes Endocrinol. 2024;12(5):287\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10084_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-025-06576-3","author":"W Aniagyei","year":"2025","unstructured":"Aniagyei W, Sarfo-Kantanka O, Mohayideen S, Vivekanandan MM, Adankwah E, Asibey SO, et al. Heterogeneity in clinically diagnosed type 1 diabetes: characterising a unique cohort with maintained C-peptide secretion in Ghana. Diabetologia. 2026;69(2):308-320 . https:\/\/doi.org\/10.1007\/s00125-025-06576-3","journal-title":"Diabetologia"},{"issue":"11","key":"10084_CR65","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S2213-8587(23)00159-6","volume":"11","author":"RD Leslie","year":"2023","unstructured":"Leslie RD, Ma RCW, Franks PW, Nadeau KJ, Pearson ER, Redondo MJ. Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes. Lancet Diabetes Endocrinol. 2023;11(11):848\u201360.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10084_CR66","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.2337\/db15-1615","volume":"65","author":"P Leete","year":"2016","unstructured":"Leete P, Willcox A, Krogvold L, Dahl-Jorgensen K, Foulis AK, Richardson SJ, et al. Differential Insulitic Profiles Determine the Extent of beta-Cell Destruction and the Age at Onset of Type 1 Diabetes. Diabetes. 2016;65(5):1362\u20139.","journal-title":"Diabetes"},{"issue":"6","key":"10084_CR67","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","volume":"63","author":"P Leete","year":"2020","unstructured":"Leete P, Oram RA, McDonald TJ, Shields BM, Ziller C, team Ts. Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. Diabetologia. 2020;63(6):1258\u201367.","journal-title":"Diabetologia"},{"issue":"2","key":"10084_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3770","volume":"40","author":"CS Weston","year":"2024","unstructured":"Weston CS, Boehm BO, Pozzilli P. Type 1 diabetes: a new vision of the disease based on endotypes. Diabetes Metab Res Rev. 2024;40(2):e3770.","journal-title":"Diabetes Metab Res Rev"},{"issue":"10267","key":"10084_CR69","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","volume":"396","author":"JCN Chan","year":"2021","unstructured":"Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2021;396(10267):2019\u201382.","journal-title":"Lancet"},{"key":"10084_CR70","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"24","key":"10084_CR71","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1001\/jama.2021.22208","volume":"326","author":"L Wang","year":"2013","unstructured":"Wang L, Peng W, Zhao Z, Zhang M, Shi Z, Song Z, et al. Prevalence and treatment of diabetes in China, 2013\u20132018. JAMA. 2013;326(24):2498\u2013506.","journal-title":"JAMA"},{"issue":"1","key":"10084_CR72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","volume":"46","author":"SE Kahn","year":"2003","unstructured":"Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 2003;46(1):3\u201319.","journal-title":"Diabetologia"},{"issue":"3","key":"10084_CR73","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/er.2007-0023","volume":"29","author":"V Poitout","year":"2008","unstructured":"Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev. 2008;29(3):351\u201366.","journal-title":"Endocr Rev"},{"issue":"10","key":"10084_CR74","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s00125-020-05245-x","volume":"63","author":"N Esser","year":"2020","unstructured":"Esser N, Utzschneider KM, Kahn SE. Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia. 2020;63(10):2007\u201321.","journal-title":"Diabetologia"},{"issue":"10","key":"10084_CR75","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1007\/s00125-021-05505-4","volume":"64","author":"JD Johnson","year":"2021","unstructured":"Johnson JD. On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes. Diabetologia. 2021;64(10):2138\u201346.","journal-title":"Diabetologia"},{"issue":"5","key":"10084_CR76","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2337\/db08-1607","volume":"58","author":"A Stancakova","year":"2009","unstructured":"Stancakova A, Javorsky M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes. 2009;58(5):1212\u201321.","journal-title":"Diabetes"},{"issue":"9","key":"10084_CR77","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.2337\/dc12-2290","volume":"36","author":"LR Staimez","year":"2013","unstructured":"Staimez LR, Weber MB, Ranjani H, Ali MK, Echouffo-Tcheugui JB, Phillips LS, et al. Evidence of reduced beta-cell function in Asian Indians with mild dysglycemia. Diabetes Care. 2013;36(9):2772\u20138.","journal-title":"Diabetes Care"},{"issue":"4","key":"10084_CR78","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.2337\/diabetes.55.04.06.db05-1100","volume":"55","author":"A Festa","year":"2006","unstructured":"Festa A, Williams K, D\u2019Agostino R Jr., Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes. 2006;55(4):1114\u201320.","journal-title":"Diabetes"},{"issue":"3","key":"10084_CR79","first-page":"942","volume":"81","author":"A Dunaif","year":"1996","unstructured":"Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81(3):942\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10084_CR80","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2337\/dc06-1834","volume":"30","author":"M Cnop","year":"2007","unstructured":"Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, et al. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care. 2007;30(3):677\u201382.","journal-title":"Diabetes Care"},{"issue":"11","key":"10084_CR81","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.2337\/dc13-0520","volume":"36","author":"RA Defronzo","year":"2013","unstructured":"Defronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, et al. Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk. Diabetes Care. 2013;36(11):3607\u201312.","journal-title":"Diabetes Care"},{"issue":"6","key":"10084_CR82","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.tem.2018.03.018","volume":"29","author":"MM Page","year":"2018","unstructured":"Page MM, Johnson JD. Mild suppression of hyperinsulinemia to treat obesity and insulin resistance. Trends Endocrinol Metab. 2018;29(6):389\u201399.","journal-title":"Trends Endocrinol Metab"},{"key":"10084_CR83","doi-asserted-by":"publisher","first-page":"100529","DOI":"10.1016\/j.lanepe.2022.100529","volume":"24","author":"ACB Thuesen","year":"2023","unstructured":"Thuesen ACB, Staeger FF, Kaci A, Solheim MH, Aukrust I, Jorsboe E, et al. A novel splice-affecting HNF1A variant with large population impact on diabetes in Greenland. Lancet Reg Health Eur. 2023;24:100529.","journal-title":"Lancet Reg Health Eur"},{"issue":"9","key":"10084_CR84","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.cmet.2025.07.007","volume":"37","author":"E Bernardo","year":"2025","unstructured":"Bernardo E, De Vas MG, Balboa D, Cuenca-Ardura M, Bonas-Guarch S, Planas-Felix M, et al. HNF1A and A1CF coordinate a beta cell transcription-splicing axis that is disrupted in type 2 diabetes. Cell Metab. 2025;37(9):1870-89 e10.","journal-title":"Cell Metab"},{"issue":"10","key":"10084_CR85","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/dom.14777","volume":"24","author":"H Pang","year":"2022","unstructured":"Pang H, Lin J, Luo S, Huang G, Li X, Xie Z, et al. The missing heritability in type 1 diabetes. Diabetes Obes Metab. 2022;24(10):1901\u201311.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10084_CR86","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s41588-019-0513-9","volume":"51","author":"OP Dwivedi","year":"2019","unstructured":"Dwivedi OP, Lehtovirta M, Hastoy B, Chandra V, Krentz NAJ, Kleiner S, et al. Loss of ZnT8 function protects against diabetes by enhanced insulin secretion. Nat Genet. 2019;51(11):1596\u2013606.","journal-title":"Nat Genet"},{"issue":"7886","key":"10084_CR87","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman JD, Li AH, Marcketta A, Sun D, Mbatchou J, Kessler MD, et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature. 2021;599(7886):628\u201334.","journal-title":"Nature"},{"issue":"1","key":"10084_CR88","doi-asserted-by":"publisher","first-page":"21565","DOI":"10.1038\/s41598-021-99091-5","volume":"11","author":"AM Deaton","year":"2021","unstructured":"Deaton AM, Parker MM, Ward LD, Flynn-Carroll AO, BonDurant L, Hinkle G, et al. Gene-level analysis of rare variants in 379,066 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes. Sci Rep. 2021;11(1):21565.","journal-title":"Sci Rep"},{"issue":"46","key":"10084_CR89","doi-asserted-by":"publisher","first-page":"eadd5430","DOI":"10.1126\/sciadv.add5430","volume":"8","author":"A Nag","year":"2022","unstructured":"Nag A, Dhindsa RS, Mitchell J, Vasavda C, Harper AR, Vitsios D, et al. Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes. Sci Adv. 2022;8(46):eadd5430.","journal-title":"Sci Adv"},{"key":"10084_CR90","doi-asserted-by":"crossref","unstructured":"Jang HM, Hwang MY, Park YS, Kim BJ, Kim YJ. SLC30A8 Rare Variant Modify Contribution of Common Genetic and Lifestyle Factors toward Type 2 Diabetes Mellitus. Diabetes Metab J. 2026;50(2):385-395 .","DOI":"10.4093\/dmj.2024.0830"},{"issue":"8","key":"10084_CR91","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.2337\/db23-0761","volume":"73","author":"LK Billings","year":"2024","unstructured":"Billings LK, Jablonski KA, Pan Q, Florez JC, Franks PW, Goldberg RB, et al. Increased Genetic Risk for beta-Cell Failure Is Associated With beta-Cell Function Decline in People With Prediabetes. Diabetes. 2024;73(8):1352\u201360.","journal-title":"Diabetes"},{"issue":"6","key":"10084_CR92","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1007\/s00125-025-06392-9","volume":"68","author":"N Zhang","year":"2025","unstructured":"Zhang N, Sun Q, Zhang J, Zhang R, Liu S, Zhao X, et al. Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes. Diabetologia. 2025;68(6):1242\u201360.","journal-title":"Diabetologia"},{"issue":"9","key":"10084_CR93","doi-asserted-by":"publisher","first-page":"109274","DOI":"10.4239\/wjd.v16.i9.109274","volume":"16","author":"A Al Madhoun","year":"2025","unstructured":"Al Madhoun A, Bahman F, Ahmad R. beta-cell dedifferentiation in type 2 diabetes: Interplay of metabolic stress, endoplasmic reticulum dysfunction, and forkhead box protein O1 inhibition. World J Diabetes. 2025;16(9):109274.","journal-title":"World J Diabetes"},{"issue":"6743","key":"10084_CR94","doi-asserted-by":"publisher","first-page":"eadf2034","DOI":"10.1126\/science.adf2034","volume":"388","author":"EM Walker","year":"2025","unstructured":"Walker EM, Pearson GL, Lawlor N, Stendahl AM, Lietzke A, Sidarala V, et al. Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues. Science. 2025;388(6743):eadf2034.","journal-title":"Science"},{"issue":"10","key":"10084_CR95","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1210\/jc.2016-2496","volume":"101","author":"AS Md Moin","year":"2016","unstructured":"Md Moin AS, Dhawan S, Cory M, Butler PC, Rizza RA, Butler AE. Increased Frequency of Hormone Negative and Polyhormonal Endocrine Cells in Lean Individuals With Type 2 Diabetes. J Clin Endocrinol Metab. 2016;101(10):3628\u201336.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10084_CR96","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1210\/jc.2015-2860","volume":"101","author":"F Cinti","year":"2016","unstructured":"Cinti F, Bouchi R, Kim-Muller JY, Ohmura Y, Sandoval PR, Masini M, et al. Evidence of beta-Cell Dedifferentiation in Human Type 2 Diabetes. J Clin Endocrinol Metab. 2016;101(3):1044\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10084_CR97","doi-asserted-by":"publisher","first-page":"107469","DOI":"10.1016\/j.celrep.2020.03.033","volume":"31","author":"CM Cohrs","year":"2020","unstructured":"Cohrs CM, Panzer JK, Drotar DM, Enos SJ, Kipke N, Chen C, et al. Dysfunction of Persisting beta Cells Is a Key Feature of Early Type 2 Diabetes Pathogenesis. Cell Rep. 2020;31(1):107469.","journal-title":"Cell Rep"},{"issue":"41","key":"10084_CR98","doi-asserted-by":"publisher","first-page":"eads2905","DOI":"10.1126\/sciadv.ads2905","volume":"11","author":"M Suleiman","year":"2025","unstructured":"Suleiman M, Sawatani T, Tesi M, Yi X, Papadopoulou T, Rufer C, et al. Functional recovery of islet beta cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches. Sci Adv. 2025;11(41):eads2905.","journal-title":"Sci Adv"},{"issue":"9","key":"10084_CR99","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S2213-8587(24)00157-8","volume":"12","author":"R Taylor","year":"2024","unstructured":"Taylor R. Understanding the cause of type 2 diabetes. Lancet Diabetes Endocrinol. 2024;12(9):664\u201373.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10084_CR100","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41467-025-68211-4","volume":"17","author":"T Yue","year":"2026","unstructured":"Yue T, Zhang W, Ding Y, Zheng X, Ma Y, Chan JCN, et al. Precision phenotyping of type 2 diabetes in chinese populations using a variational autoencoder-informed tree model. Nat Commun. 2026;17(1):1475.","journal-title":"Nat Commun"},{"issue":"6","key":"10084_CR101","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s11892-015-0602-9","volume":"15","author":"D Yabe","year":"2015","unstructured":"Yabe D, Seino Y, Fukushima M, Seino S. beta cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Curr Diab Rep. 2015;15(6):602.","journal-title":"Curr Diab Rep"},{"issue":"5","key":"10084_CR102","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, Karajamaki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 1","key":"10084_CR103","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice C. 2","year":"2024","unstructured":"American Diabetes Association Professional Practice C. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20\u201342.","journal-title":"Diabetes Care"},{"issue":"5","key":"10084_CR104","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1210\/endrev\/bnac003","volume":"43","author":"A Sweeting","year":"2022","unstructured":"Sweeting A, Wong J, Murphy HR, Ross GP. A Clinical Update on Gestational Diabetes Mellitus. Endocr Rev. 2022;43(5):763\u201393.","journal-title":"Endocr Rev"},{"key":"10084_CR105","doi-asserted-by":"publisher","first-page":"j1","DOI":"10.1136\/bmj.j1","volume":"356","author":"PM Catalano","year":"2017","unstructured":"Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017;356:j1.","journal-title":"BMJ"},{"issue":"12","key":"10084_CR106","doi-asserted-by":"publisher","first-page":"105405","DOI":"10.1016\/j.jbc.2023.105405","volume":"299","author":"TO Usman","year":"2023","unstructured":"Usman TO, Chhetri G, Yeh H, Dong HH. Beta-cell compensation and gestational diabetes. J Biol Chem. 2023;299(12):105405.","journal-title":"J Biol Chem"},{"key":"10084_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145003","author":"EU Alejandro","year":"2020","unstructured":"Alejandro EU, Mamerto TP, Chung G, Villavieja A, Gaus NL, Morgan E, et al. Gestational diabetes mellitus: a harbinger of the vicious cycle of diabetes. Int J Mol Sci. 2020;21(14):5003. https:\/\/doi.org\/10.3390\/ijms21145003","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10084_CR108","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","volume":"5","author":"HD McIntyre","year":"2019","unstructured":"McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"10084_CR109","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2337\/dbi24-0041","volume":"74","author":"TA Buchanan","year":"2025","unstructured":"Buchanan TA, Xiang AH, Page KA, Watanabe RM. What is gestational diabetes\u2014really? Diabetes. 2025;74(7):1037\u201346.","journal-title":"Diabetes"},{"issue":"4","key":"10084_CR110","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0002-9378(99)70662-9","volume":"180","author":"PM Catalano","year":"1999","unstructured":"Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol. 1999;180(4):903\u201316.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10084_CR111","first-page":"568","volume":"86","author":"C Homko","year":"2001","unstructured":"Homko C, Sivan E, Chen X, Reece EA, Boden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab. 2001;86(2):568\u201373.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10084_CR112","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.2337\/dc07-s201","volume":"30","author":"TA Buchanan","year":"2007","unstructured":"Buchanan TA, Xiang A, Kjos SL, Watanabe R. What is gestational diabetes? Diabetes Care. 2007;30(Suppl 2):S105\u201311.","journal-title":"Diabetes Care"},{"key":"10084_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052320","author":"R Mittal","year":"2025","unstructured":"Mittal R, Prasad K, Lemos JRN, Arevalo G, Hirani K. Unveiling gestational diabetes: an overview of pathophysiology and management. Int J Mol Sci. 2025;26(5):2320. https:\/\/doi.org\/10.3390\/ijms26052320","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10084_CR114","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41588-023-01607-4","volume":"56","author":"A Elliott","year":"2024","unstructured":"Elliott A, Walters RK, Pirinen M, Kurki M, Junna N, Goldstein JI, et al. Distinct and shared genetic architectures of gestational diabetes mellitus and type 2 diabetes. Nat Genet. 2024;56(3):377\u201382.","journal-title":"Nat Genet"},{"issue":"9","key":"10084_CR115","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.2337\/dc24-0022","volume":"47","author":"J Choi","year":"2024","unstructured":"Choi J, Lee H, Kuang A, Huerta-Chagoya A, Scholtens DM, Choi D, et al. Genome-Wide Polygenic Risk Score Predicts Incident Type 2 Diabetes in Women With History of Gestational Diabetes. Diabetes Care. 2024;47(9):1622\u20139.","journal-title":"Diabetes Care"},{"issue":"2","key":"10084_CR116","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2337\/db11-1034","volume":"61","author":"SH Kwak","year":"2012","unstructured":"Kwak SH, Kim SH, Cho YM, Go MJ, Cho YS, Choi SH, et al. A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes. 2012;61(2):531\u201341.","journal-title":"Diabetes"},{"issue":"19","key":"10084_CR117","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1093\/hmg\/ddac050","volume":"31","author":"N Pervjakova","year":"2022","unstructured":"Pervjakova N, Moen GH, Borges MC, Ferreira T, Cook JP, Allard C, et al. Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Hum Mol Genet. 2022;31(19):3377\u201391.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10084_CR118","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1507\/endocrj.EJ23-0245","volume":"70","author":"Y Li","year":"2023","unstructured":"Li Y, Yang M, Yuan L, Li T, Zhong X, Guo Y. Associations between a polygenic risk score and the risk of gestational diabetes mellitus in a Chinese population: a case-control study. Endocr J. 2023;70(12):1159\u201368.","journal-title":"Endocr J"},{"issue":"10","key":"10084_CR119","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.2337\/db10-0521","volume":"59","author":"AH Xiang","year":"2010","unstructured":"Xiang AH, Kjos SL, Takayanagi M, Trigo E, Buchanan TA. Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes. 2010;59(10):2625\u201330.","journal-title":"Diabetes"},{"key":"10084_CR120","doi-asserted-by":"publisher","first-page":"1157416","DOI":"10.3389\/fendo.2023.1157416","volume":"14","author":"H Fuller","year":"2023","unstructured":"Fuller H, Iles MM, Moore JB, Zulyniak MA. Metabolic drivers of dysglycemia in pregnancy: ethnic-specific GWAS of 146 metabolites and 1-sample Mendelian randomization analyses in a UK multi-ethnic birth cohort. Front Endocrinol (Lausanne). 2023;14:1157416.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10084_CR121","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-3016.2010.01140.x","volume":"24","author":"MM Hedderson","year":"2010","unstructured":"Hedderson MM, Darbinian JA, Ferrara A. Disparities in the risk of gestational diabetes by race-ethnicity and country of birth. Paediatr Perinat Epidemiol. 2010;24(5):441\u20138.","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"4","key":"10084_CR122","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1530\/EJE-12-0452","volume":"167","author":"K Morkrid","year":"2012","unstructured":"Morkrid K, Jenum AK, Sletner L, Vardal MH, Waage CW, Nakstad B, et al. Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes. Eur J Endocrinol. 2012;167(4):579\u201388.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10084_CR123","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3904\/kjim.2013.28.3.294","volume":"28","author":"EH Jang","year":"2013","unstructured":"Jang EH, Kwon HS. beta-Cell dysfunction and insulin resistance in gestational glucose intolerance. Korean J Intern Med. 2013;28(3):294\u20136.","journal-title":"Korean J Intern Med"},{"issue":"9","key":"10084_CR124","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.2337\/dc14-0573","volume":"37","author":"W Li","year":"2014","unstructured":"Li W, Zhang S, Liu H, Wang L, Zhang C, Leng J, et al. Different associations of diabetes with beta-cell dysfunction and insulin resistance among obese and nonobese Chinese women with prior gestational diabetes mellitus. Diabetes Care. 2014;37(9):2533\u20139.","journal-title":"Diabetes Care"},{"key":"10084_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/nu14122444","author":"J Ellerbrock","year":"2022","unstructured":"Ellerbrock J, Spaanderman B, Drongelen JV, Mulder E, Lopes van Balen V, Schiffer V, et al. Role of beta cell function and insulin resistance in the development of gestational diabetes mellitus. Nutrients. 2022;14(12):2444. https:\/\/doi.org\/10.3390\/nu14122444","journal-title":"Nutrients"},{"issue":"11","key":"10084_CR126","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1007\/s00125-019-4961-7","volume":"62","author":"K Benhalima","year":"2019","unstructured":"Benhalima K, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S, Verlaenen H, et al. Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance. Diabetologia. 2019;62(11):2118\u201328.","journal-title":"Diabetologia"},{"issue":"2","key":"10084_CR127","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00125-020-05323-0","volume":"64","author":"LR Madsen","year":"2021","unstructured":"Madsen LR, Gibbons KS, Ma RCW, Tam WH, Catalano PM, Sacks DA, et al. Do variations in insulin sensitivity and insulin secretion in pregnancy predict differences in obstetric and neonatal outcomes? Diabetologia. 2021;64(2):304\u201312.","journal-title":"Diabetologia"},{"issue":"4","key":"10084_CR128","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/1753-0407.13113","volume":"13","author":"N Wang","year":"2021","unstructured":"Wang N, Song L, Sun B, Peng Y, Fei S, Cui J, et al. Contribution of gestational diabetes mellitus heterogeneity and prepregnancy body mass index to large-for-gestational-age infants-A retrospective case-control study. J Diabetes. 2021;13(4):307\u201317.","journal-title":"J Diabetes"},{"issue":"2","key":"10084_CR129","doi-asserted-by":"publisher","first-page":"241 e1","DOI":"10.1016\/j.ajog.2021.08.016","volume":"226","author":"DJ Selen","year":"2022","unstructured":"Selen DJ, Edelson PK, James K, Corelli K, Hivert MF, Meigs JB, et al. Physiological subtypes of gestational glucose intolerance and risk of adverse pregnancy outcomes. Am J Obstet Gynecol. 2022;226(2):241 e1-e14.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10084_CR130","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00125-024-06110-x","volume":"67","author":"K Lee","year":"2024","unstructured":"Lee K, Kuang A, Bain JR, Hayes MG, Muehlbauer MJ, Ilkayeva OR, et al. Metabolomic and genetic architecture of gestational diabetes subtypes. Diabetologia. 2024;67(5):895\u2013907.","journal-title":"Diabetologia"},{"issue":"9","key":"10084_CR131","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41574-025-01129-5","volume":"21","author":"M Lytrivi","year":"2025","unstructured":"Lytrivi M, Tong Y, Virgilio E, Yi X, Cnop M. Diabetes mellitus and the key role of endoplasmic reticulum stress in pancreatic beta cells. Nat Rev Endocrinol. 2025;21(9):546\u201363.","journal-title":"Nat Rev Endocrinol"},{"key":"10084_CR132","doi-asserted-by":"publisher","first-page":"1772399","DOI":"10.3389\/fimmu.2026.1772399","volume":"17","author":"R Mittal","year":"2026","unstructured":"Mittal R, Alipour F, Doshi J, Mittal M, Hirani K. Stress-driven remodeling of antigen presentation and chemokine signaling in pancreatic beta-cells: implications for type 1 diabetes. Front Immunol. 2026;17:1772399.","journal-title":"Front Immunol"},{"issue":"5","key":"10084_CR133","doi-asserted-by":"publisher","first-page":"103420","DOI":"10.1016\/j.dsx.2026.103420","volume":"20","author":"H Kumar","year":"2026","unstructured":"Kumar H, Kumari R, Maurya VK, Amar SK, Ansari P, Seidel V, et al. Endoplasmic reticulum stress in diabetes mellitus: A comprehensive review of emerging insights and recent progress. Diabetes metabolic syndrome. 2026;20(5):103420.","journal-title":"Diabetes metabolic syndrome"},{"key":"10084_CR134","doi-asserted-by":"crossref","unstructured":"Darwish R, Alcibahy Y, Abu-Sharia G, Butler AE. beta-Cell Mitochondrial Dysfunction: Underlying Mechanisms and Potential Therapeutic Strategies. Cells. 2025;14(23):1861.","DOI":"10.3390\/cells14231861"},{"issue":"5","key":"10084_CR135","doi-asserted-by":"publisher","first-page":"101678","DOI":"10.1016\/j.diabet.2025.101678","volume":"51","author":"N Ng","year":"2025","unstructured":"Ng N, Sanchez-Lechuga B, McCarrick CJ, Mangan C, Burke M, Ioana JA, et al. Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A\u2009>\u2009G mutations. Diabetes Metab. 2025;51(5):101678.","journal-title":"Diabetes Metab"},{"key":"10084_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2026.156466","volume":"282","author":"T Lu","year":"2026","unstructured":"Lu T, Qiang W, Ye Q. Cytokines and chemokines in diabetes: immunopathogenesis, therapeutic targets, and future perspectives across all disease forms. Pathol Res Pract. 2026;282:156466.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"10084_CR137","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1530\/JOE-17-0516","volume":"236","author":"M Bensellam","year":"2018","unstructured":"Bensellam M, Jonas JC, Laybutt DR. Mechanisms of beta-cell dedifferentiation in diabetes: recent findings and future research directions. J Endocrinol. 2018;236(2):R109\u201343.","journal-title":"J Endocrinol"},{"key":"10084_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1427723","volume":"15","author":"KL Webster","year":"2024","unstructured":"Webster KL, Mirmira RG. Beta cell dedifferentiation in type 1 diabetes: sacrificing function for survival? Front Endocrinol (Lausanne). 2024;15:1427723.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10084_CR139","doi-asserted-by":"publisher","first-page":"1698296","DOI":"10.3389\/fcell.2025.1698296","volume":"13","author":"E Ruchko","year":"2025","unstructured":"Ruchko E, Chernysheva M, Sokolov V, Starinnov Z, Sabirov M, Vasiliev A. beta-cell heterogeneity and molecular plasticity in type 2 diabetes: multi-omics perspectives and the role of gut microbiota. Front Cell Dev Biol. 2025;13:1698296.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"10084_CR140","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.cmet.2024.09.006","volume":"36","author":"EK Sokolowski","year":"2024","unstructured":"Sokolowski EK, Kursawe R, Selvam V, Bhuiyan RM, Thibodeau A, Zhao C, et al. Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights. Cell Metab. 2024;36(11):2468-88 e7.","journal-title":"Cell Metab"},{"issue":"1","key":"10084_CR141","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.1038\/s41467-025-62670-5","volume":"16","author":"RB Kang","year":"2025","unstructured":"Kang RB, Varela M, Oh E, Lee J, Zhang T, Karakose E, et al. Human pancreatic alpha-cell heterogeneity and trajectory inference analyses reveal SMOC1 as a beta-cell dedifferentiation gene. Nat Commun. 2025;16(1):8434.","journal-title":"Nat Commun"},{"issue":"11","key":"10084_CR142","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11892-018-1085-2","volume":"18","author":"RKP Benninger","year":"2018","unstructured":"Benninger RKP, Dorrell C, Hodson DJ, Rutter GA. The Impact of Pancreatic Beta Cell Heterogeneity on Type 1 Diabetes Pathogenesis. Curr Diab Rep. 2018;18(11):112.","journal-title":"Curr Diab Rep"},{"issue":"9","key":"10084_CR143","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.2337\/db21-0211","volume":"70","author":"SD Nimkulrat","year":"2021","unstructured":"Nimkulrat SD, Bernstein MN, Ni Z, Brown J, Kendziorski C, Blum B. The Anna Karenina Model of beta-Cell Maturation in Development and Their Dedifferentiation in Type 1 and Type 2 Diabetes. Diabetes. 2021;70(9):2058\u201366.","journal-title":"Diabetes"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10084-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-026-10084-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10084-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:02:29Z","timestamp":1787940149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-026-10084-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":143,"alternative-id":["10084"],"URL":"https:\/\/doi.org\/10.1007\/s11154-026-10084-z","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}